Research on remedy for Congo's Ebola
A clinical trial is underway in Congo to test an experimental antiviral pill aimed at preventing Ebola infection among individuals exposed to the Bundibugyo virus, which is responsible for the current outbreak. Over 250 participants, including health workers and family members of infected individuals, have enrolled since July in the study, which seeks to evaluate the drug's effectiveness as post-exposure prophylaxis. The outbreak has recorded more than 8,300 confirmed cases and approximately 4,000 deaths, with efforts ongoing to contain and slow its spread.
articleDetails.fontSize.sizeحجم النص
تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي
comments.heading